Market capitalization | $41.23m |
Enterprise Value | $47.43m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.97 |
P/S ratio (TTM) P/S ratio | 0.84 |
P/B ratio (TTM) P/B ratio | 2.80 |
Revenue growth (TTM) Revenue growth | 3.36% |
Revenue (TTM) Revenue | $49.03m |
As a Free StocksGuide user, you can view scores for all 6,907 stocks worldwide.
5 Analysts have issued a Apyx Medical Corporation forecast:
5 Analysts have issued a Apyx Medical Corporation forecast:
Jun '24 |
+/-
%
|
||
Revenue | 49 49 |
3%
3%
|
|
Gross Profit | 11 11 |
6%
6%
|
|
EBITDA | -22 -22 |
7%
7%
|
EBIT (Operating Income) EBIT | -23 -23 |
6%
6%
|
Net Profit | -28 -28 |
74%
74%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Head office | United States |
CEO | Charles Goodwin |
Employees | 252 |
Founded | 1978 |
Website | apyxmedical.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.